Geneeskundige Stichting Koningin Elisabeth

Top

Universiteiten & ploegen

Universiteiten met onderzoeksprogramma's die gesteund worden door de G.S.K.E.

Universiteiten met onderzoeksprogramma's UA UA UGent UGent VUB VUB KU Leuven KU Leuven UMons UMons ULB ULB ULg ULg UCL UCL


ruler

Onderzoeksprogramma’s gefinancierd door de G.S.K.E.
Programma 2008-2010

Onderzoeksprogramma KU Leuven

KU Leuven

  • Prof. dr. Peter Carmeliet
    Unraveling the role and therapeutic potential of Flt1 receptor ligands in amyotrophic lateral sclerosis (ALS).
  • Prof. dr. Peter Janssen
    The presentation of three-dimensional shape in posterior parietal and premotor cortex of the rhesus monkey.
  • Prof. dr. Wim Vanduffel
    Large-scale causal functional interactions between cortical areas: from anatomy to neuro-pharmacology.
  • Prof. dr. Rufin Vogels
    Coding of biological motion in macaque monkeys: relating perception and neuronal selectivity.
Onderzoeksprogramma UA

UA

Onderzoeksprogramma voor de UCL

UCL

  • Prof. dr. André Goffinet
    Genetic, molecular and cellular mechanisms of cortical development.
  • Dr. Emmanuel Hermans
    Cellular crosstalks in amyotrophic lateral sclerosis: influence of neuroinflammation on astrocyte function and stem cell differentiation.
Onderzoeksprogramma UGent

UGent

  • Prof. dr. Frans Van Roy
    Functional analysis of novel adhesive and signaling proteins in development and tumorigenesis of neural tissues.
Onderzoeksprogramma ULB

ULB

Onderzoeksprogramma ULg

ULg

  • Prof. dr. Pierre Maquet
    Characterization of spontaneous brain activity in unconscious participants by multimodal functional neuroimaging.
  • Prof. dr. Gustave Moonen
    Characterization of new cellular and molecular mechanism underlying migration of interneurons in the telencephalon.
Onderzoeksprogramma UMons

UMons

  • Dr. Laurence Ris
    Role of protein synthesis in late long-term potentiation (L-LTP).
Onderzoeksprogramma VUB

VUB

  • Prof. dr. Yvette Michotte
    Exploration of the memory enhancing effects of angiotensin IV and unravelling its mechanism of action.